1 Correction to: Drugs (2018) 78(14):1501–1508 https://doi.org/10.1007/s40265-018-0977-4
The article Elagolix: First Global Approval, written by Yvette N. Lamb, was originally published Online First without open access. After publication in volume 78, issue 14, pages 1501–1508 AbbVie Inc., requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by AbbVie Inc. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Lamb, Y.N. Correction to: Elagolix: First Global Approval. Drugs 78, 1855 (2018). https://doi.org/10.1007/s40265-018-1014-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-018-1014-3